At the news
? NEUTRALIMPACT 4/10 CLUSTER filed Feb 25, 2026 at 19:00 ET
Two senior executives at BioMarin Pharmaceutical sold shares in the past week, with total open-market proceeds of approximately $1.98 million. The sales represent modest insider selling, while two other executives received non-cash stock awards. The selling activity is notable but not extreme relative to the company's $11.8B market cap.
- EVP and Chief Legal Officer George Eric Davis sold 26,061 shares for $1.60M in open-market transactions.
- EVP and Chief R&D Officer Gregory Friberg sold 6,326 shares for $381,937.
- Two other executives (Davis and CFO Brian Mueller) received non-cash stock awards totaling 12,860 shares with no monetary value exchanged.
- Total open-market selling value: $1.98 million (0.017% of $11.8B market cap).
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access